Clinical Trial Update: A Study to Evaluate Zilebesiran in Japanese Patients With Mild to Moderate Hypertension [Phase 1, Phase 2]

View source ↗

Summary

This clinical trial update reports the completion of Phase 1 and Phase 2 studies of Zilebesiran in Japanese patients with mild to moderate hypertension.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension

Drugs mentioned

• Zilebesiran

Snippet

Sponsor: Alnylam Pharmaceuticals | Conditions: Mild to Moderate Hypertension | Phase 1, Phase 2 | Status: COMPLETED